债券代码：127045 债券简称：牧原转债 牧原食品股份有限公司 关于 2024 年年度权益分派实施后 调整回购价格上限的公告 证券代码：002714 证券简称：牧原股份 公告编号：2025-062 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 一、回购股份的基本情况 牧原食品股份有限公司（以下简称"公司"）于2024年9月25日召开的第四 届董事会第二十九次会议审议通过了《关于回购公司股份的议案》，公司拟使 用自有资金或自筹资金以集中竞价交易的方式回购公司发行的人民币普通股 （A股），回购总金额不低于人民币30亿元且不超过人民币40亿元（均含本 数），回购价格不超过人民币58.60元/股（含本数）。按回购金额上限人民币40 亿元、回购价格上限58.60元/股测算，预计可回购股数约为6,825.94万股，占公 司目前总股本的1.25%；按回购金额下限人民币30亿元、回购价格上限58.60元/ 股测算，预计可回购股数约为5,119.45万股，占公司目前总股本的0.94%。具体 回购股份的数量以回购期满时实际回购的股份数量为准。公司本次回购的股份 将 ...

北京晶品特装科技股份有限公司（以下简称"公司"）于 2025 年 6 月 17 日召 开了第二届董事会第十一次会议，审议通过了《关于使用部分超募资金以集中竞 价交易方式回购公司股份方案的议案》，具体详见公司于 2025 年 6 月 18 日在上 海证券交易所网站(www.sse.com.cn)披露的《关于以集中竞价方式回购股份的回购 报告书》（公告编号：2025-021）。 证券代码：688084 证券简称：晶品特装 公告编号：2025-022 北京晶品特装科技股份有限公司 关于回购股份事项前十大股东和前十大无限售条件 股东持股情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 份方案前一个交易日（即 2025 年 6 月 17 日）登记在册的前十大股东和前十大无 限售条件股东的名称、持股数量及持股比例公告如下： 通股的比例（%） 一、公司前十大股东持股情况 占公司总股本的比例 | | | （%） 中国银行股份有限公司－广发中小盘 精选混合型证券投资基 ...

证券代码：603773 证券简称：沃格光电 公告编号：2025-048 关于股份回购实施完成暨股份变动的公告 江西沃格光电集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购方案首次披露日 2025/4/22 回购方案实施期限 2025 年 4 月 21 日~2026 年 4 月 20 日 预计回购金额 1,500万元~2,500万元 回购价格上限 35元/股 □减少注册资本 √用于员工持股计划或股权激励 回购用途 | | □用于转换公司可转债 | | --- | --- | | | □为维护公司价值及股东权益 | | 实际回购股数 | 678,100股 | | 实际回购股数占总股本比例 | 0.30% | | 实际回购金额 | 1,500.77万元 | | 实际回购价格区间 | 20.83元/股~23.00元/股 | | 一、 | 回购审批情况和回购方案内容 | 三、 回购期间相关主体买卖股票情况 证券交易所网站（www.sse.com.cn）披露的《江西沃格光电集团股份有限公司关 于以集中 ...

Core Viewpoint - Nanjing Novogene Bioinformatics Technology Co., Ltd. plans to repurchase its shares through centralized bidding, with a total repurchase amount ranging from RMB 5 million to RMB 10 million, aimed at implementing equity incentives or employee stock ownership plans [1][4][6]. Summary by Relevant Sections Repurchase Plan Details - The repurchase amount is set between RMB 5 million and RMB 10 million [1][4]. - The funding source for the repurchase will be the company's own funds [1][4]. - The maximum repurchase price is capped at RMB 30 per share, which does not exceed 150% of the average trading price over the last 30 trading days prior to the board's decision [1][4][6]. - The repurchase will be conducted through the Shanghai Stock Exchange's trading system [1][5]. - The duration for the repurchase is within 12 months from the board's approval date [1][4]. Purpose and Use of Repurchased Shares - The repurchased shares will be used for implementing equity incentives or employee stock ownership plans [1][4][8]. - If the company fails to implement these plans within three years after the repurchase, the unutilized shares will be canceled [1][4][12]. Shareholder and Management Plans - Major shareholders, including the actual controller and board members, have no plans to reduce their holdings in the next three to six months [2][10][11]. - The proposal for the repurchase was initiated by the actual controller and chairman, Mr. Cao Lin, based on confidence in the company's future development [12][13]. Financial Impact and Structure Changes - As of March 31, 2025, the company's total assets were RMB 5.266 billion, with net assets attributable to shareholders at RMB 3.901 billion [8]. - The repurchase amount, if at the upper limit of RMB 10 million, would represent approximately 0.02% of total assets and 0.26% of net assets [8]. - The repurchase is expected to have no significant impact on the company's operations, financial status, or future development [8]. Compliance and Authorization - The repurchase plan has been approved by more than two-thirds of the board members and does not require shareholder meeting approval [3][4]. - The management is authorized to handle all matters related to the repurchase, including adjustments to the plan as necessary [13][14].

Core Viewpoint - The legal opinion letter from Yuanwen (Shanghai) Law Firm confirms the legality and compliance of Suzhou Mingzhi Technology Co., Ltd.'s differentiated dividend distribution for the fiscal year 2024, ensuring it aligns with relevant laws and regulations [1][8]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is necessitated by the company's repurchased shares, which do not participate in profit distribution as per the relevant laws and regulations [4][5]. - The company plans to distribute a cash dividend of 4.50 yuan per 10 shares (including tax), excluding the 534,750 shares held in the repurchase account from this distribution [5][6]. - The total number of shares eligible for profit distribution is calculated to be 123,421,322 shares after excluding the repurchased shares from the total share capital of 123,956,072 shares [6][7]. Group 2: Legal Compliance and Verification - The law firm has conducted thorough verification of the legal compliance of the differentiated dividend distribution, ensuring no false records or misleading statements exist [2][3]. - The legal opinion letter serves as a necessary legal document for the company's differentiated dividend distribution and is subject to legal responsibility by the law firm [2][3]. - The law firm emphasizes that it only provides opinions on legal matters related to the differentiated dividend distribution and does not assess accounting or financial aspects [3][4].

Core Viewpoint - The company, Fujian Nanwang Environmental Technology Co., Ltd., has successfully completed its share repurchase plan, utilizing between 20 million and 40 million RMB of its own funds to buy back shares for potential employee stock ownership plans or equity incentives [2][3]. Summary by Sections Share Repurchase Plan - The company announced a share repurchase plan on June 25, 2024, with a budget of 20 million to 40 million RMB, adjusting the maximum repurchase price from 15 RMB to 14.9 RMB per share [2]. - The estimated number of shares to be repurchased ranges from 1,342,282 to 2,684,563, representing 0.6880% to 1.3760% of the total share capital [2]. Implementation Status - As of the announcement date, the company has repurchased a total of 1,773,100 shares, accounting for 0.9088% of the total share capital, with a total expenditure of 20,024,048 RMB [3]. - The highest and lowest prices for the repurchased shares were 12.60 RMB and 9.35 RMB, respectively [3]. Compliance and Impact - The share repurchase was conducted in accordance with relevant regulations and did not deviate from the approved plan [3]. - The implementation of the repurchase will not significantly impact the company's financials, operations, or control structure [3]. Future Arrangements - The repurchased shares will not have voting rights or be subject to pledging and lending, and any unused shares will be canceled after three years [6]. Share Structure Changes - The share structure before and after the repurchase indicates a slight shift in the proportion of restricted and unrestricted shares, with restricted shares decreasing from 50.28% to 49.55% and unrestricted shares increasing from 49.72% to 50.45% [5].

诺唯赞公告，公司拟以500万元至1000万元资金回购股份，回购价格不超过30元/股(含)。回购股份将全 部用于实施股权激励或员工持股计划，预计回购股份数量为16.67万股至33.33万股，占公司总股本的 0.04%-0.08%。回购期限为董事会审议通过之日起12个月内，资金来源为公司自有资金。公司控股股 东、实际控制人及董监高等未来3个月、6个月内均无减持计划。 ...

中信证券股份有限公司 关于辽宁成大生物股份有限公司 以集中竞价交易方式回购公司股份的核查意见 中信证券股份有限公司（以下简称"保荐机构"或"中信证券"）作为辽宁 成大生物股份有限公司（以下简称"成大生物"或"公司"）首次公开发行股票 并在科创板上市的持续督导保荐机构，根据《上海证券交易所科创板上市公司自 律监管指引第 1 号——规范运作》《上市公司募集资金监管规则》《上海证券 交易所上市公司自律监管指引第 7 号——回购股份》等有关规定，对公司以集 中竞价交易方式回购股份的事项进行了核查，具体情况如下： 一、回购方案的审议及实施程序 金通过上海证券交易所交易系统以集中竞价交易方式回购公司已发行的部分人 民币普通股（A股）股票。具体内容详见 公司在上海证券交易所网站 （www.sse.com.cn）披露的《辽宁成大生物股份有限公司关于公司董事长提议回 购公司股份的提示性公告》（公告编号：2025-032）。 以集中竞价交易方式回购公司股份方案的议案》。公司全体董事出席会议，表决 结果为9票同意、0票反对、0票弃权，经三分之二以上董事出席的董事会会议决 议通过。根据《上市公司股份回购规则》及《公司章程》之规定，本 ...

Core Viewpoint - The company plans to repurchase its shares with a budget ranging from 10 million to 20 million RMB, indicating a strategic move to enhance shareholder value [1] Summary by Relevant Sections - **Share Repurchase Plan** - The company intends to use its own or raised funds to buy back shares, with a total budget set between 10 million RMB (1,000,000) and 20 million RMB (2,000,000) [1] - The maximum repurchase price is capped at 18 RMB per share [1] - The implementation period for the share repurchase is set for 12 months from the date of the board's approval [1]

证券代码：688739 证券简称：成大生物 公告编号：2025-033 辽宁成大生物股份有限公司 第五届董事会第十九次会议决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 二、董事会会议审议情况 审议通过《关于以集中竞价交易方式回购公司股份方案的议案》 公司本次回购股份符合《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购 股份》等法律法规、规范性文件的有关规定。董事会一致同意公司使用不低于人民币 股（含），以集中竞价交易方式回购公司已发行的人民币普通股股票，并在未来适宜 时机全部用于员工持股计划或股权激励。具体回购资金总额以实际使用的资金总额为 准。同时，为高效、有序、顺利地完成本次公司回购股份工作，董事会授权公司管理 层在法律法规规定的范围内办理本次回购股份的相关事宜。 表决结果:赞成票 9 票、反对票 0 票、弃权票 0 票 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）披露的《关 ...